Few tumors and cancers have a single cause, but in the case of dog dewormer cancer, it appears that a genetic mutation may be to blame. Fibrosarcomas are soft tissue sarcomas that commonly affect the limbs, but can also be found on the trunk or inside the mouth. They can be very aggressive, with fast growth and rapid spread of the disease.
The most common treatment for fibrosarcomas is surgery to remove the tumor, followed by radiation and sometimes chemotherapy. Chemotherapy is less effective with sarcomas than with other types of cancers, but it can help shrink the size of the tumor and slow its progression. Some dogs can benefit from a form of chemotherapy called metronomic chemotherapy, in which low doses of chemotherapy drugs are administered daily.
When Joe Tippens of Edmond, Oklahoma, was diagnosed with late-stage lung cancer in 2016, he was told that he had just three months to live. He didn’t want to accept the prognosis, and he began searching for alternatives to pharmaceutical medicine. He combed the web, trying spices like curcumin and CBD oil and mega-doses of vitamin E. But he also tried something that has scientists scratching their heads: a dog dewormer.
Fenbendazole is a veterinary medication approved by the FDA to eliminate parasites in cats and dogs. It’s most often sold under the brand name Panacur C. The drug has not been tested in people with cancer, but Tippens was willing to be a guinea pig. He claims that after just a few months on the drug, his PET scan came back clear. dog dewormer cancer